Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes-Reference-Cited by-同舟云学术

Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes

Published:2015-09-15 Issue:11 Volume:33 Page:1152-1158
ISSN:1087-0156
Container-title:Nature Biotechnology
language:en
Short-container-title:Nat Biotechnol

Author:

Shukla Sachet A,Rooney Michael S,Rajasagi Mohini,Tiao Grace,Dixon Philip M,Lawrence Michael S,Stevens Jonathan,Lane William J,Dellagatta Jamie L,Steelman Scott,Sougnez Carrie,Cibulskis Kristian,Kiezun Adam,Hacohen Nir,Brusic Vladimir,Wu Catherine J,Getz Gad

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

http://www.nature.com/articles/nbt.3344.pdf

Reference47 articles.

1. Stransky, N. et al. The mutational landscape of head and neck squamous cell carcinoma. Science 333, 1157–1160 (2011).

2. Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature 489, 519–525 (2012).

3. Lohr, J.G. et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc. Natl. Acad. Sci. USA 109, 3879–3884 (2012).

4. Lawrence, M.S. et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505, 495–501 (2014).

5. Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513, 202–209 (2014).

Cited by 553 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel framework for human leukocyte antigen (HLA) genotyping using probe capture-based targeted next-generation sequencing and computational analysis;Computational and Structural Biotechnology Journal;2024-12

2. Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer;Cancer Cell;2024-09

3. HLA-A*02:01allele is associated with decreased risk and a longer survival in pancreatic cancer: Results from an exhaustive analysis of theHLAvariation in PDAC;2024-08-29

4. Comprehensive molecular characterization of collecting duct carcinoma for therapeutic vulnerability;EMBO Molecular Medicine;2024-08-09

5. The genomic landscape of 2,023 colorectal cancers;Nature;2024-08-07